Azusa, CA, United States of America

Mohamad H Abedi

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mohamad H Abedi: Innovator in T-Cell Immunotherapy

Introduction

Mohamad H Abedi is a prominent inventor based in Azusa, California. He has made significant contributions to the field of immunotherapy, particularly in the regulation of T-cells. With a total of 3 patents, his work focuses on innovative methods to enhance the effectiveness of T-cell therapies.

Latest Patents

Abedi's latest patents include groundbreaking technologies for the thermal control of T-cell immunotherapy. One of his notable inventions involves methods, compositions, and kits designed for spatiotemporal regulation of therapeutic T-cells. This technology utilizes thermal bioswitches that enable T-cells to detect minor temperature changes, which serve as inputs for the activation of genetic circuits. Additionally, he has developed T-cell activity sensors and genetic circuits that can induce the expression of therapeutic payloads upon thermal or immune cell stimulation. His work also encompasses thermally actuated immune cells and methods to prevent T-cell exhaustion.

Career Highlights

Abedi is affiliated with the California Institute of Technology, where he continues to push the boundaries of immunotherapy research. His innovative approaches have the potential to revolutionize how T-cell therapies are administered and monitored.

Collaborations

Abedi collaborates with esteemed colleagues, including Mikhail G Shapiro and Dan I Piraner, to further advance the field of immunotherapy.

Conclusion

Mohamad H Abedi's contributions to T-cell immunotherapy exemplify the intersection of innovation and medical science. His patents reflect a commitment to improving therapeutic outcomes for patients through advanced technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…